ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC

Thesis

Atlas Venture is a prominent biotechnology venture capital firm founded in 1980 and headquartered in Cambridge, Massachusetts. They specialize in seed-led venture creation, focusing on translating groundbreaking science into life-changing medicines through a science-first, patient-centric, and collaborative approach. The firm actively partners with scientists and entrepreneurs, often co-founding or incubating companies, and takes a hands-on approach with rigorous scientific evaluation and a focus on patient outcomes. Their primary investment sectors are biotechnology and life sciences, with specific interests in gene therapy, precision oncology, RNA-modifying proteins, and novel therapeutic modalities. Their geographic scope is predominantly North America, with a strong concentration in Cambridge, Massachusetts. The firm often leads early-stage rounds, takes active operational involvement, and provides follow-on funding. As of December 2024, their fourteenth fund totaled $450 million, with Opportunity Fund II at $300 million (Sept 2021) and a third Opportunity Fund at $400 million (Sept 2025). Their total AUM is $2.7 billion. Typical check sizes range from $2 million to $15 million for early-stage companies, with seed investments typically between $500,000 and $1,000,000.

Related lists

• Seed investors based in Cambridge, MA
• Series A investors based in Cambridge, MA
• Series C+ investors based in Cambridge, MA